ArticleNature communications2026
An agent-guided peptide hydrogel bio-stabilizer clamps pericellular viscoelastic drift.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Living tissues continually remodel the extracellular matrix, causing pericellular mechanics to drift over time. Chronic glycation amplifies this drift, destabilizing mechanoregulatory cues and compromising regenerative outcomes. Here we introduce Micro-Mechanical Homeostasis Reset, a material-based strategy that targets cell-to-pericellular viscoelastic homeostasis rather than static bulk stiffness. Using an agent-guided, rule-based enumeration-and-scoring workflow, we design ViscoClamp, an extracellular matrix-interpenetrating peptide hydrogel with affinity for calcium ions and advanced glycation end products. We show that ViscoClamp buffers chronic glycation loading and constrains glycation-driven viscoelastic drift, while remaining permissive to mesenchymal stem cell-mediated matrix remodeling and mineralization. We quantify stabilization using a dispersion-transfer ratio that measures how variable glycation inputs are compressed into stable micromechanical outputs. We demonstrate that in glycation-rich hyperglycemic craniofacial defects, ViscoClamp stabilizes cell-scale micromechanics, restores osteogenic activation, and improves bone repair and mineralization in rats, rabbits, beagle dogs, and rhesus macaques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.